Glenmark Pharmaceuticals Fundamentals
P/E Ratio
57.5
P/B Ratio
6.13
Div. Yield
0.12
Sector P/E
59.54
Sector P/B
2.65
Sec. Div. Yield
0.59
Glenmark Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 57.5, compared to the sector average of 59.54. Its P/B Ratio stands at 6.13, while the sector’s is 2.65. In terms of returns, the stock offers a Dividend Yield of 0.12%, which is than the sector’s 0.59%.
Glenmark Pharmaceuticals Score Card
Price
Expensive
Growth
Moderate
Quality
Good
Management
Good
On its scorecard, Glenmark Pharmaceuticals reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Glenmark Pharmaceuticals Associated Pages
- Glenmark Pharmaceuticals Share Price
- Glenmark Pharmaceuticals Share Price chart
- Glenmark Pharmaceuticals Technical Analysis
- Glenmark Pharmaceuticals Peer Comparison
- Glenmark Pharmaceuticals Share Price History
- Glenmark Pharmaceuticals Dividend
- Glenmark Pharmaceuticals Board of Directors
- Glenmark Pharmaceuticals Shareholding Pattern
